European Journal of Medical Sciences Eur J Med Sci Dec; 1(4): Tear Film Osmolarity in Diagnosis of Dry Eye Syndrome

Size: px
Start display at page:

Download "European Journal of Medical Sciences Eur J Med Sci Dec; 1(4): Tear Film Osmolarity in Diagnosis of Dry Eye Syndrome"

Transcription

1 Review Article Tear Film Osmolarity in Diagnosis of Dry Eye Syndrome H.Murat Sagdikˡ, Sinan Caliskan², Mehmet Tetikogluˡ, Serdar Aktasˡ, Fatma Ucar³, Fatih Ozcuraˡ 1 Department of Ophthalmology, Dumlupinar University School of Medicine, Kütahya, Turkey 2 Department of Ophthalmology, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey 3 Department of Clinical Biochemistry, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey Abstract Dry eye disease (DED) is a multifactorial disease which is characterized by the symptoms including burning, dryness, itching, pain, foreign body sensation and watering eyes. As causative mechanisms, the tear hyperosmolarity and tear film instability may initiate the dry eye. Increased tear osmolarity and ocular surface inflammation have a key role in the pathogenesis of DED. Tear osmolarity has been an exciting issue as in the diagnosis and management of DED. Herein, we discussed the role of tear osmolarity in the diagnosis procedures of DED. Keywords: Dry Eye Syndrome, Tear Film Osmolarity Corresponding Author: H. Murat SAGDIK. Department of Ophthalmology, Dumlupinar University School of Medicine, Kütahya, Turkey Introduction Dry eye is a multifactorial disease mainly related to altered tears and ocular surface. Although, the prevalence of dry eye disease (DED) varies with the selected population, applied dry eye criteria and geographic location, it is estimated about 5% to 30%(1). Dry eye causes symptoms including burning, dryness, itching, pain, foreign body sensation and watering eyes. Although the mechanism of the DED not fully understood, tears film instability and inflammation construct the core mechanism. Ocular inflammation is a secondary consequence which leads to epithelial damage(2). The tear composition can be compromised secondary to decreased lacrimal tears secretion or increased tears evaporation. Classification of the DED can be grouped as etiopathology, causative mechanism, severity of disease and dry eye symptoms(3). The etiopathogenic classification of dry eye disease includes two major categories: aqueous teardeficient dry eye and evaporative dry eye. As causative mechanisms, the tear hyperosmolarity and tear film instability may initiate the dry eye and alter the course of DED. 117

2 Role of Osmolarity in Etiopathogenesis of Dry eye Normal tear osmolarity is roughly 295 mosmol/l which is isotonic with blood(1). Lacrimal gland failure and/or excessive evaporation from tears film leads to reduced aqueous tear flow and increased tear osmolarity. It s considered that tear hyperosmolarity is the main actor which cause ocular surface inflammation, damage, and symptoms, and the initiation of compensatory events in dry eye(4). Increased osmolarity with sodium or sucrose, induce activation of epithelial signaling molecule cascade, production of proinflammatory mediators and matrix metalloproteinases (MMPs) by conjunctival and corneal epithelial cells (5, 6). Local apoptotic cell death, decreased conjunctival goblet cell is also associated with a tear hyperosmolarity (7-9). As a first compensatory mechanism response to ocular surface damage, reflex tears secretion and blink rate increases which controlled by trigeminal reflex activity. Diagnosis of Dry Eye Dry eye diagnostic tests used to discriminate dry eye and its subsets, monitoring of therapy and identify poor candidates for the ocular procedure. Although, various diagnostic techniques have been described for the diagnosis of dry eye, five main groups of dry eye diagnostic test will be discussed below. a) Symptom Questionnaires Several symptom questionnaires have been developed for use in dry eye diagnosis. The questionnaires most commonly used are The Ocular Surface Disease Index (OSDI), McMonnies Dry Eye Index and Dry Eye Questionnaire (DEQ)(10).Although the symptom questionnaire able to distinguish dry eye and non-dry eye groups, there is no always correlation between dry eye tests and symptoms (11, 12). The questionnaires may allow for rapid and efficient collection of relevant information by utilizing trained auxiliary staff but their length and composition and the time taken to administer and interpreting may not be practical in general clinical use (4, 13). The Dry Eye Workshop (DEWS) reports suggest the structured questionnaire for screening patients with potential dry eye disease. a) Grading Ocular Surface Staining Ocular surface staining is an invasive procedure to assess ocular surface damage by instilling a dye such as sodium fluorescein, Rose Bengal, or lissamine green. Currently, fluorescein and lissamine green dyes are mostly used in clinical practice. Fluorescein dye is an orange dye, seems green when excited by blue light. When there is a epithelial cell-to-cell junction s damage, it stains cornea, conjunctiva epithelia and may shows different pattern according to underlying causes (14). Advantages of fluorescein are well tolerated, cause minimal irritation, stain both cornea and conjunctiva epithelium. After instillation of fluorescein does not allow optimal observation of the ocular surface immediately, but improves some seconds or minutes later after diluted by the tears and blinking (14). The Rose Bengal dye has been used for many years in the diagnosis of dry eye (15). It s believed that Rose Bengal stains degenerated or dead cells and mucous strands, however, Feenstra et al. postulated that it also stain vital which loss the normal mucin layer and protective function of the preocular tear film (16). The main disadvantages of Rose Bengal is a great discomfort due to Rose Bengal toxicity which induces a loss of vitality, even cellular death and light exposure exacerbate cell toxicity (17). Lissamin green has been used as a substitute for Rose Bengal because of the less toxic structure. Both of them shows similar staining properties 118

3 (18). To standardize subjective ocular staining reading, there are several grading systems, comprising the van Bijsterveld system, the Oxford Scheme, and the National Eye Institute/Industry Workshop guidelines. However, there are no published studies that show one is superior to another (19). c) Tear Film Stability Tear film stability can be assessed with invasive tear break-up time (TBUT) and noninvasive break-up time (NIBUT). Currently, TBUT is the most commonly used test to asses tears film quality(20). TBUT is defined as the interval between the last complete blink and the appearance of a random break or disruption in the tear film after application of a standard volume of fluorescein. Although 1mL of 2% fluorescein solution improve the repeatability of TBUT measurement, excessive fluorescein volume, over the average tear volume of 6 to 7 ml may increase TBUT artificially(21). The cutoff time recommended for the diagnosis of DED was 5 seconds and < 10 seconds suggest unstable tear film(4, 22). d) Tear Flow the Schirmer Test The Schirmer tear test has been used to indirectly measure the volume of tears(23). The Schirmer I test measure reflex and basal tear production without prior installation of an anesthetic drops. A variation of the Schirmer I with instillation of a topical anesthetic measures basal tear production(10). The Schirmer II test with nasal stimulation with a cotton tip applicator only measure reflex secretion of tears. Recently, the Schirmer type 1 performed without anesthesia have a cut-off of < 5 mm/5 min for tear deficiency and a value greater 10 mm/5 min is accepted as normal (23, 24). Although repeatability of The Schirmer I test improved in advanced dry eye disease, it has a wide variation between subjects and visits (25, 26). e) Tear Osmolarity The tear film maintain a vital hemostatic function for epithelium and anterior stroma by delivering or excreting the nutrients and metabolic products(27). There is a dynamic equilibrium in the production, evaporation, absorption and drainage of the tear film. Any disequilibrium leads to alteration of the tear film structure and composition, eventually leading to tear film hyperosmolarity(28). Both osmolality and osmolarity terms used to describe the amount of osmotically active particles; however, there is a small differences between the two terms(29). Osmolality is defined as the total number of dissolved solute particles in one kilogram of solution and osmolarity as the number of osmoles per litre of solution. Osmolarity is temperature dependent by way of the solution of volume changes with temperature. If a solute is dissolved in a solvent, it shows some chemical properties which is known as colligative properties including: increase in osmotic pressure, increase boiling point, decrease in vapor pressure and decrease in freezing point properties(30, 31). These are all directly related to osmolarity and could be used as a basis for the measurement of osmolality. The most common method for measuring osmotic pressure in the clinic was the freezing point depression(32). I. Freezing point depression osmometer The osmometers such as Clifton nanoliter osmometer (Clifton Technical Physics of Hartford, NY), Advanced Tear Osmometer (Advanced Instruments, Inc, Norwood, MA) and the Otago Osmometer (Otago Osmometers, Ltd, Dunedin, New Zealand) used to measure tear osmolarity with the freezing point depression 119

4 methods(33, 34). The temperature of the freezing point is directly proportional to the total number of dissolved particles in the tear sample. Thus, the osmolarity can be calculated from the depression in the freezing point of the tear sample(35). The methods require significant expertise, takes considerable time, potential errors due to evaporation of test sample and temperature rate changes could not be controlled reliably(33, 35). II. Vapor pressure osmometer The measurement of osmolarity with vapor pressure depression depends on the principle that the vapor pressure of a solution is lower than that of the pure solvent at the same temperature and pressure. Vapor pressure depression is proportional to the number of dissolved particles in the solution (35, 36). Recently, vapor pressure osmometers, such as the Wescor (Wescor, Inc, Logan, UT) have been used in the clinical settings. It requires relatively a larger sample volume 2 µl and needs saturating a cellulose acetate disc to collect the tears (37, 38). Both freezing point depression and vapor pressure techniques needs to the tear collection and transferred for measurement, both collection ( reflex tears secretion) and transfer (evaporation) may cause unreliable measurements (39). III. Electrical impedance Electrical impedance is not a colligative property of the solution. Measurement of tears osmolarity using electrical conductivity or impedance is a newly developed technique that measures only charged particles and depends on conductivity is dependent on the number of particles (35, 40). The OcuSense TearLab osmometer (OcuSense Inc., San Diego, CA, USA) uses a temperaturecorrected impedance measurement and provides instant assessment of tear osmolarity(38). It uses the disposable a non-sterile and disposable osmolarity test card. The card system contain a microchip which has a microfluidic channel to collect the tears and a gold electrode embedded in the polycarbonate plate to enable measurement of the impedance of the sample(38). The TearLab require 50 nl tear sample for the measurement (41). Although the system have advantages such as, portable, require a small volume sample, eliminated risk of evaporation during transfer, real time measurement of both eyes, the possible disadvantages of the TearLab are the reasonably difficult standardization, avoiding the induction of reflex tearing(40, 42). The electrical conductivity is dependent on the number of charged particles, it could be argued that unappreciated, uncharged particle limits the conductivity technique for measuring osmolarity. The recommended diagnostic cut-off of 316 mosm/l has been well validated (4, 43). In a recent study, the devices utilizing the electrical impedance and the freezing point depression technique was compared, and found a slight difference with the devices utilizing the electrical impedance producing lower values, but a good correlation with each other(35). Eperjesi et al. found noise value as 33 mosms/l with repeated OcuSense TearLab osmometer tear osmolarity readings over time which means only increases or decreases of more than 33 mosms/l can be classed as clinically relevant for healthy subjects(38). With an aspect that all types of dry eyes eventually leads to increase in tear osmolarity, the measurement of tear osmolarity may be seems the best diagnostic test for dry eye. Khanal et postulated that tear hyperosmolarity has the potential to be a gold standard for dry eye diagnosis, tear osmolarity is ineffective in differentiating between aqueous deficient dry eye and evaporative dry eye(44). Although, recent studies reports that tear osmolarity is the best marker, correlates with dry eye severity (45-120

5 47), tear film osmolarity testing couldn t distinguish between dry eye disease and healthy group(48). Sullivan et al. found that there was no consistent relationship between common symptoms and signs (including tear osmolarity) of DED (49). A multifactorial etiopathogenesis, the heterogeneity of the condition, may contribute to the lack of correlation with the other signs of dry eye disease (50). In conclusion, it is obvious that tear osmolarity test has been a valuable diagnostic test and promising test for DED diagnosis and monitorization of the treatment. Combinations of diagnostic tests should be used to assess symptoms and clinical signs of DED. References: 1. Holland EJ, Mannis MJ, Lee WB. Ocular surface disease : cornea, conjunctiva and tear film. London ; New York Elsevier/Saunders; p Mantelli F, Massaro-Giordano M, Macchi I, Lambiase A, Bonini S. The cellular mechanisms of dry eye: from pathogenesis to treatment. J Cell Physiol. 2013;228(12): listed. Na. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2): The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2): Li D-Q, Luo L, Chen Z, Kim H-S, Song XJ, Pflugfelder SC. JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res. 2006;82(4): Corrales RM, Luo L, Chang EY, Pflugfelder SC. Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells. Cornea. 2008;27(5): Versura P, Profazio V, Schiavi C, Campos EC. Hyperosmolar stress upregulates HLA-DR expression in human conjunctival epithelium in dry eye patients and in vitro models. Invest Ophthalmol Vis Sci. 2011;52(8): Moore JE, Vasey GT, Dartt DA, McGilligan VE, Atkinson SD, Grills C, et al. Effect of tear hyperosmolarity and signs of clinical ocular surface pathology upon conjunctival goblet cell function in the human ocular surface. Invest Ophthalmol Vis Sci. 2011;52(9): Julio G, Lluch S, Pujol P, Merindano MD. Effects of tear hyperosmolarity on conjunctival cells in mild to moderate dry eye. Ophthalmic Physiol Opt. 2012;32(4): Tavares FdP, Fernandes RS, Bernardes TF, Bonfioli AA, Soares EJC. Dry eye disease. Semin Ophthalmol. 2010;25(3): Simpson TL, Situ P, Jones LW, Fonn D. Dry eye symptoms assessed by four questionnaires. Optom Vis Sci. 2008;85(8): Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23(8): McGinnigle S, Naroo SA, Eperjesi F. Evaluation of dry eye. Survey of ophthalmology. 2012;57(4): Murube J. Fluorescein: the most commonly used surfocular vital stain. Ocul Surf. 2013;11(3): Doughty MJ, Glavin S. Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review. Ophthalmic Physiol Opt. 2009;29(6): Feenstra RP, Tseng SC. What is actually stained by rose bengal? Arch Ophthalmol. 1992;110(7): Murube J. Rose bengal: the second most commonly used surfocular vital stain. Ocul Surf. 2014;12(1): Machado LM, Castro RS, Fontes BM. Staining patterns in dry eye syndrome: rose bengal versus lissamine green. Cornea. 2009;28(7): Zeev MS-B, Miller DD, Latkany R. Diagnosis of dry eye disease and emerging technologies. Clin Ophthalmol. 2014;8: Smith J, Nichols KK, Baldwin EK. Current patterns in the use of diagnostic tests in dry eye evaluation. Cornea. 2008;27(6):

6 21. Sweeney DF, Millar TJ, Raju SR. Tear film stability: a review. Exp Eye Res. 2013;117: Bron AJ. Diagnosis of dry eye. Survey of ophthalmology. 2001;45:S221-S Bitton E, Wittich W. Influence of eye position on the Schirmer tear test. Contact lens & anterior eye : the journal of the British Contact Lens Association Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Annals of the rheumatic diseases. 2002;61(6): Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea. 2004;23(3): Cho P, Yap M. Schirmer test. I. A review. Optom Vis Sci. 1993;70(2): Tiffany JM. Tears in health and disease. Eye (London, England). 2003;17(8): Tomlinson A, Khanal S. Assessment of tear film dynamics: quantification approach. Ocul Surf. 2005;3(2): Stahl U, Willcox M, Stapleton F. Osmolality and tear film dynamics. Clinical & experimental optometry : journal of the Australian Optometrical Association. 2012;95(1): Andrews FC. Colligative properties of simple solutions. Science (New York, NY). 1976;194(4265): Lord RC. Osmosis, osmometry, and osmoregulation. Postgraduate medical journal. 1999;75(880): Murube J. Tear osmolarity. The ocular surface. 2006;4(2): Braslavsky I, Drori R. LabVIEWoperated novel nanoliter osmometer for ice binding protein investigations. Journal of visualized experiments : JoVE. 2013(72):e Yildiz EH, Fan VC, Banday H, Ramanathan LV, Bitra RK, Garry E, et al. Evaluation of a new tear osmometer for repeatability and accuracy, using 0.5-microL (500-Nanoliter) samples. Cornea. 2009;28(6): Tomlinson A, McCann LC, Pearce EI. Comparison of human tear film osmolarity measured by electrical impedance and freezing point depression techniques. Cornea. 2010;29(9): Kolling WM, McPherson TB. Assessment of the accuracy of pharmacy students' compounded solutions using vapor pressure osmometry. American journal of pharmaceutical education. 2013;77(3): Pensyl CD, Benjamin WJ. Vapor pressure osmometry: minimum sample microvolumes. Acta ophthalmologica Scandinavica. 1999;77(1): Eperjesi F, Aujla M, Bartlett H. Reproducibility and repeatability of the OcuSense TearLab osmometer. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2012;250(8): Gokhale M, Stahl U, Jalbert I. In situ osmometry: validation and effect of sample collection technique. Optom Vis Sci. 2013;90(4): Jacobi C, Jacobi A, Kruse FE, Cursiefen C. Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea. 2011;30(12): Benelli U, Nardi M, Posarelli C, Albert TG. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness. Contact lens & anterior eye : the journal of the British Contact Lens Association. 2010;33(2): Li M, Du C, Zhu D, Shen M, Cui L, Wang J. Daytime variations of tear osmolarity and tear meniscus volume. Eye & contact lens. 2012;38(5): Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47(10): Khanal S, Tomlinson A, Diaper CJ. Tear physiology of aqueous deficiency and evaporative dry eye. Optom Vis Sci. 2009;86(11): Versura P, Profazio V, Campos EC. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Current eye research. 2010;35(7): Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, et al. An 122

7 objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51(12): Suzuki M, Massingale ML, Ye F, Godbold J, Elfassy T, Vallabhajosyula M, et al. Tear osmolarity as a biomarker for dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51(9): Messmer EM, Bulgen M, Kampik A. Hyperosmolarity of the tear film in dry eye syndrome. Developments in ophthalmology. 2010;45: Sullivan BD, Crews LA, Messmer EM, Foulks GN, Nichols KK, Baenninger P, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta ophthalmologica. 2014;92(2): Versura P, Campos EC. TearLab(R) Osmolarity System for diagnosing dry eye. Expert review of molecular diagnostics. 2013;13(2):

Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon A silicone hydrogel

Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon A silicone hydrogel Int Ophthalmol (2012) 32:229 233 DOI 10.1007/s10792-012-9556-y ORIGINAL PAPER Comparison of tear osmolarity and ocular comfort between daily disposable contact lenses: hilafilcon B hydrogel versus narafilcon

More information

The first comprehensive definition of DED was published in

The first comprehensive definition of DED was published in Special Issue Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions Jun Shimazaki Department of Ophthalmology, Tokyo Dental College, Ichikawa General Hospital,

More information

Financial Disclosures

Financial Disclosures March 19, 2015 Financial Disclosures Consultant: Alcon Allergan Bausch & Lomb Modernizing Medicine Ophthalmologyweb.co m Investor: Novabay Ophthotech Ocular Surface Disease Ocular surface disease is often

More information

Tear Osmolarity and its role in Optometric Practice & Contact Lens Success

Tear Osmolarity and its role in Optometric Practice & Contact Lens Success Tear Osmolarity and its role in Optometric Practice & Contact Lens Success Nick Dash: Optometrist Declaration of Association Director: See2wiN Ltd (Accuvision/Visual Edge/SportsVision Institute) Honorary

More information

Assessment of tear film osmolarity using the TearLab TM osmometer in normal dogs and dogs with keratoconjunctivitis sicca

Assessment of tear film osmolarity using the TearLab TM osmometer in normal dogs and dogs with keratoconjunctivitis sicca Veterinary Ophthalmology (2016) 1 8 DOI:10.1111/vop.12436 Assessment of tear film osmolarity using the TearLab TM osmometer in normal dogs and dogs with keratoconjunctivitis sicca Lionel Sebbag,*,1,3 Shin

More information

Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren s Syndrome

Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren s Syndrome pissn: 111-8942 eissn: 292-9382 Korean J Ophthalmol 217;31(1):25-31 https://doi.org/1.3341/kjo.217.31.1.25 Original Article Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary

More information

Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD

Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD Title: Keeping Step with DEWS2: Clinical Applications Lecturer: Scott G. Hauswirth, OD Course Description: The Dry Eye Workshop 2 was an assemblage of experts in dry eye disease from around the world,

More information

pat hways Medtech innovation briefing Published: 15 December 2015 nice.org.uk/guidance/mib47

pat hways Medtech innovation briefing Published: 15 December 2015 nice.org.uk/guidance/mib47 pat hways TearLab osmolarity system for diagnosing dry eye disease Medtech innovation briefing Published: 15 December 2015 nice.org.uk/guidance/mib47 Summary The TearLab osmolarity system is a point-of-care

More information

Inflammatory Cytokine and Osmolarity Changes in the Tears of Dry Eye Patients Treated with Topical 1% Methylprednisolone

Inflammatory Cytokine and Osmolarity Changes in the Tears of Dry Eye Patients Treated with Topical 1% Methylprednisolone Original Article http://dx.doi.org/10.3349/ymj.2014.55.1.203 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 55(1):203-208, 2014 Inflammatory Cytokine and Osmolarity Changes in the Tears of Dry Eye Patients

More information

Dry eye disease was recently redefined as a multifactorial

Dry eye disease was recently redefined as a multifactorial CLINICAL SCIENCE Ocular Surface Workup With Automated Noninvasive Measurements for the Diagnosis of Meibomian Gland Dysfunction Giuseppe Giannaccare, MD, PhD,* Luca Vigo, MD, Marco Pellegrini, MD,* Stefano

More information

Investor Presentation. October 2018

Investor Presentation. October 2018 Investor Presentation October 2018 2 Our Mission Creating a New Paradigm Our platform uses tears to diagnose disease Proprietary nano-fluidic technology that leverages molecular data from the tear film

More information

Optimizing the Ocular Surface. Presentation Title. Charlene M. Grice, Carolina Eyecare Physicians, LLC

Optimizing the Ocular Surface. Presentation Title. Charlene M. Grice, Carolina Eyecare Physicians, LLC Optimizing the Ocular Surface Presentation Title Presenter Charlene M. Grice, Name MD Carolina Eyecare Physicians, LLC Financial Disclosures I have no financial disclosures. I will discuss off label use

More information

OS3 The TearLab Ocular Surface Severity Scale Benjamin D. Sullivan, Ph.D. (760)

OS3 The TearLab Ocular Surface Severity Scale Benjamin D. Sullivan, Ph.D. (760) OS3 The TearLab Ocular Surface Severity Scale Benjamin D. Sullivan, Ph.D. bdsulliv@tearlab.com (760) 224-4595 The Ocular Surface Severity Scale (OS 3 ) was originally developed as a way to compare the

More information

Ophthalmology Times Case Study Yasmin Mali, MD. Case Study

Ophthalmology Times Case Study Yasmin Mali, MD. Case Study Ophthalmology Times Case Study Yasmin Mali, MD Case Study A 57 year old female with presented with ocular irritation and discomfort in both eyes for several months. Patient was previously started on a

More information

JMSCR Vol 05 Issue 02 Page February 2017

JMSCR Vol 05 Issue 02 Page February 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i2.155 Prevalence of Dry Eye Diseases in the

More information

Dry eye syndrome in diabetic children

Dry eye syndrome in diabetic children European Journal of Ophthalmology / Vol. 17 no. 6, 2007 / pp. 873-878 Dry eye syndrome in diabetic children A. AKINCI 1, E. CETINKAYA 2, Z. AYCAN 2 1 Department of Pediatric Ophthalmology 2 Department

More information

1998 DESCRIPTION Evaluation of Subjective and Objective tests for diagnosing tear-film disorders known to cause ocular irritation.

1998 DESCRIPTION Evaluation of Subjective and Objective tests for diagnosing tear-film disorders known to cause ocular irritation. DEWS DRY EYE: DIAGNOSTIC TEST TEMPLATE RAPPORTEUR A.J.Bron 18 th Oct 2004 TEST Mixed tests TO Ocular Irritation / Dry Eye REFERENCES DIAGNOSE VERSION of TEST Multiple tests DESCRIPTION Evaluation of Subjective

More information

1. Department of Ophthalmology, Pacific Medical College and Hospital, Udaipur, Rajasthan, India

1. Department of Ophthalmology, Pacific Medical College and Hospital, Udaipur, Rajasthan, India International Journal of Medical Science and Education An official Publication of Association for Scientific and Medical Education (ASME) www.ijmse.com Original Research Article pissn- 2348 4438 eissn-2349-3208

More information

Ocular Surface Disease. Advanced Treatment in Ocular Surface Disease. Disclosures. Revenue Potential. Chronic Dry Eye Should I Treat It

Ocular Surface Disease. Advanced Treatment in Ocular Surface Disease. Disclosures. Revenue Potential. Chronic Dry Eye Should I Treat It Advanced Treatment in Ocular Surface Disease Douglas K. Devries, O.D. Eye Care Associates of Nevada Douglas K. Devries Consultant or Speakers Bureau for Allergan AMO TearLab NicOx BVI B&L Disclosures Chronic

More information

Learn Connect Succeed. JCAHPO Regional Meetings 2017

Learn Connect Succeed. JCAHPO Regional Meetings 2017 Learn Connect Succeed JCAHPO Regional Meetings 2017 Unveiling Dry Eye Evaluation LOOKING AT DRY EYE DIFFERENTLY: GAINING KNOWLEDGE AND SKILL BY MARTHA TELLO, COMT,OSC, BGS JCAHPO MIAMI, FLORIDA CONTINUING

More information

What is the Value of Incorporating Tear Osmolarity Measurement in Assessing Patient Response to Therapy in Dry Eye Disease?

What is the Value of Incorporating Tear Osmolarity Measurement in Assessing Patient Response to Therapy in Dry Eye Disease? What is the Value of Incorporating Tear Osmolarity Measurement in Assessing Patient Response to Therapy in Dry Eye Disease? The Harvard community has made this article openly available. Please share how

More information

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM

Dry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM Page 1 of 13 BEFORE COMPLETING THE OCULAR EXAMINATION, YOU MUST BE ABLE TO ANSWER YES TO THE FOLLOWING QUESTIONS: Have you done MMP9? (SVonly) The Following are done at Baseline: Have you done Tear Osmolarity?

More information

A DRY EYE DISEASE DECISION TREE

A DRY EYE DISEASE DECISION TREE A DRY EYE DISEASE DECISION TREE With the DEWS guidelines almost 10 years old, new approaches are needed. BY JASON SCHMIT, OD I am sometimes asked about medical decision-making by students, interns, fellows,

More information

Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work?

Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work? See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/282816021 Does in-office manual expression for Meibomian Gland Dysfunction (MGD) work? Conference

More information

Author's response to reviews

Author's response to reviews Author's response to reviews Title:Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: results from a multicenter, open-label, randomized, controlled study Authors:

More information

Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye...

Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye... Overview & pathophysiology of Dry Eye and the use of cyclosporine eye drops in dry eye... This Allergan sponsored session was held on July 24, 2005, Hotel Satya Ashoka, Jabalpur. The session was followed

More information

Advanced Diagnosis and Management of OSD and Tear Dysfunction

Advanced Diagnosis and Management of OSD and Tear Dysfunction Advanced Diagnosis and Management of OSD and Tear Dysfunction Arthur B. Epstein, OD, FAAO Phoenix, Eye Care & The Dry Eye Center of Arizona Phoenix, AZ, USA Our understanding of the ocular surface has

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Uchino Y, Uchino M, Yokoi N, et al. Alteration of tear mucin 5AC in office workers using visual display terminals: the Osaka Study. JAMA Ophthalmol. Published online June 5,

More information

Evidence for Technology in the Treatment of Advanced Dry Eye

Evidence for Technology in the Treatment of Advanced Dry Eye Evidence for Technology in the Treatment of Advanced Dry Eye COPE 44435-AS Chris Lievens, OD, MS, FAAO Evidence for Technology in the Treatment of Advanced Dry Eye COPE: 44435-AS Chris Lievens, OD MS FAAO

More information

Dr.Sushil Kumar Tripathi

Dr.Sushil Kumar Tripathi Rabamipide:360 Benefits in Dry eye syndrome Dr.Sushil Kumar Tripathi Prevalence of Dry Eye Syndrome: vone in four patients attending ophthalmic clinics report symptoms of dry eye. vprevalence of dry eye

More information

Forward Looking Statements

Forward Looking Statements Forward Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include but are not limited

More information

Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D Kensington Blvd. Bowling Green, OH 43402

Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D Kensington Blvd. Bowling Green, OH 43402 Dry Eye Disease Diagnosis and Treatment Pearls from the Trenches (2 hours) Mile Brujic, O.D. 1409 Kensington Blvd. Bowling Green, OH 43402 Summary As our understanding of dry eye disease has evolved, so

More information

1/16/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX.

1/16/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX drbilltownsend@gmail.com 1 Alcon CIBA Odyssey Medical Science Based Health Shire TearLab Any product

More information

RECENT ADVANCES IN THE MANAGEMENT AND TREATMENT OF DRY EYE DISEASE

RECENT ADVANCES IN THE MANAGEMENT AND TREATMENT OF DRY EYE DISEASE RECENT ADVANCES IN THE MANAGEMENT AND TREATMENT OF DRY EYE DISEASE FRANCESCO CARONES, MD MEDICAL DIRECTOR AND PHYSICIAN CEO CARONES VISION, MILAN - ITALY FINANCIAL DISCLOSURES Francesco Carones, MD consults

More information

How to Create a Dry Eye Center

How to Create a Dry Eye Center How to Create a Dry Eye Center Whitney Hauser, OD Signal Ophthalmic Consulting Disclosures TearScience Consultant/Speaker NovaBay Speaker BioTissue - Speaker Lumenis Consultant/Speaker Shire Consultant/Speaker

More information

Incidence of dry eye in a sample population in Kuala Lumpur

Incidence of dry eye in a sample population in Kuala Lumpur Incidence of dry eye in a sample population in Kuala Lumpur Bariah Mohd-Ali, Leong Set Fee, Haliza Abdul-Mutalib, Norhani Mohidin Vol. 3 No. 11 (November 2011) International Journal of Collaborative Research

More information

Incidence Of Dry Eye Disesase In People Living With Acquired Immuodeficiency Synrome

Incidence Of Dry Eye Disesase In People Living With Acquired Immuodeficiency Synrome IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 9 Ver. X (September). 2016), PP 41-46 www.iosrjournals.org Incidence Of Dry Eye Disesase In

More information

Dry eye syndrome (DES), as defined by

Dry eye syndrome (DES), as defined by Signs and Symptoms in Dry Eye Confirm the diagnosis of dry eye before beginning treatment. BY GIANCARLO MONTANI, OPTOM FIACLE, FBCLA; AND UMBERTO BENELLI, MD, PHD Dry eye syndrome (DES), as defined by

More information

Current Practice Pattern for Dry Eye Patients in South Korea: A Multicenter Study

Current Practice Pattern for Dry Eye Patients in South Korea: A Multicenter Study pissn: 11-8942 eissn: 92-9382 Korean J Ophthalmol 14;28(2):115-121 http://dx.doi.org/.3341/kjo.14.28.2.115 Original Article Current Practice Pattern for Dry Eye Patients in South Korea: A Multicenter Study

More information

VARIABILITY IS A HALLMARK OF DRY EYE DISEASE

VARIABILITY IS A HALLMARK OF DRY EYE DISEASE VARIABILITY IS A HALLMARK OF DRY EYE DISEASE Christopher E. Starr, MD, FACS Associate Professor of Ophthalmology Director, Refractive Surgery Director, Cornea, Cataract & Refractive Surgery Fellowship

More information

HELP HEAL YOUR PATIENTS DRY EYES.

HELP HEAL YOUR PATIENTS DRY EYES. HELP HEAL YOUR PATIENTS DRY EYES. REFRESH REPAIR promotes healing of the cornea and conjunctival epithelia, and improves visual performance in Dry Eye patients. REF115081_v2 12/18 FIRST AND ONLY ARTIFICIAL

More information

BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE

BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE In this article, Christian Roesky, PhD, Chief Executive Officer, Novaliq, discusses the underserved condition of dry eye disease, and presents two products

More information

MEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY?

MEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY? MEIBOMIAN GLAND DYSFUNCTION & DRY EYE: WHAT DO THE EXPERTS SAY? Alan G. Kabat, OD, FAAO (901) 252-3691 Memphis, Tennessee alan.kabat@alankabat.com Course description: This course reviews the latest thoughts,

More information

Evaluation of Dry Eye: A Hospital Based Study

Evaluation of Dry Eye: A Hospital Based Study IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 9 Ver. XI (September. 2017), PP 44-49 www.iosrjournals.org Evaluation of : A Hospital Based

More information

Diagnostics. Traditionally, clinicians have made the diagnosis. cover story. Join the renaissance!

Diagnostics. Traditionally, clinicians have made the diagnosis. cover story. Join the renaissance! Dry Eye Diagnostics Join the renaissance! By John D. Sheppard, MD, MMSc Traditionally, clinicians have made the diagnosis of dry eye disease (DED) based on a patient s history, slit-lamp examination, Schirmer

More information

Screening of dry eye disease in visual display terminal workers during occupational health examinations: The Moriguchi study

Screening of dry eye disease in visual display terminal workers during occupational health examinations: The Moriguchi study Motoko KAWASHIMA, et al.: Screening of dry eye in visual display terminal workers J Occup Health 2015; 57: 253 258 253 Journal of Occupational Health Screening of dry eye disease in visual display terminal

More information

Clinical Study Presence of Dry Eye in Patients with Hashimoto s Thyroiditis

Clinical Study Presence of Dry Eye in Patients with Hashimoto s Thyroiditis Ophthalmology, Article ID 754923, 4 pages http://dx.doi.org/10.1155/2014/754923 Clinical Study Presence of Dry Eye in Patients with Hashimoto s Thyroiditis Emrah Kan, 1 Elif KJlJçkan, 2 Gulçin EcemiG,

More information

Automated Tear Film Surface Quality Breakup Time as a Novel Clinical Marker for Tear Hyperosmolarity in Dry Eye Disease

Automated Tear Film Surface Quality Breakup Time as a Novel Clinical Marker for Tear Hyperosmolarity in Dry Eye Disease Cornea Automated Tear Film Surface Quality Breakup Time as a Novel Clinical Marker for Tear Hyperosmolarity in Dry Eye Disease Laura Elizabeth Downie Department of Optometry and Vision Sciences, Faculty

More information

Immunology and Pathophysiology of Dry Eye

Immunology and Pathophysiology of Dry Eye Immunology and Pathophysiology of Dry Eye Associate Prof. Banu Bozkurt, MD, FEBO MSc in Immunology Selcuk University Medical Faculty, Konya, Turkey 47th PanHellenic Ophthalmology Congress 28-31 May 2014,

More information

A Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction

A Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction CLINICAL SCIENCE A Randomized Double-Masked Study of 0.05% Cyclosporine Ophthalmic Emulsion in the Treatment of Meibomian Gland Dysfunction Pinnita Prabhasawat, MD, Nattaporn Tesavibul, MD, and Wannaree

More information

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Policy Number: 9.03.29 Last Review: 12/2017 Origination: 9/2013 Next Review: 5/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue

More information

Dry eye disease is multifactorial in aetiology and complex in pathophysiology that makes its diagnosis clinically challenging.

Dry eye disease is multifactorial in aetiology and complex in pathophysiology that makes its diagnosis clinically challenging. Diagnostic Tools for Dry Eye Disease Sarah Dougherty Wood and Shahzad I Mian Department of Ophthalmology and Visual Sciences, Medical School, University of Michigan, Ann Arbor, Michigan, US DOI: https://doi.org/10.17925/eor.2016.10.02.101

More information

QUALITATIVE INTERPRETATION OF VISUAL ACUITY IN DRY EYE PATIENTS

QUALITATIVE INTERPRETATION OF VISUAL ACUITY IN DRY EYE PATIENTS Bulletin of the Transilvania University of Braşov Special Issue Series VI: Medical Sciences Vol. 10 (59) No. 2-2017 QUALITATIVE INTERPRETATION OF VISUAL ACUITY IN DRY EYE PATIENTS C. TRIHENEA 1 A. STANILA

More information

Local Coverage Determination (LCD): Diagnostic Evaluation and Medical Management of Moderate-Severe Dry Eye Disease (DED) (L36232)

Local Coverage Determination (LCD): Diagnostic Evaluation and Medical Management of Moderate-Severe Dry Eye Disease (DED) (L36232) Local Coverage Determination (LCD): Diagnostic Evaluation and Medical Management of Moderate-Severe Dry Eye Disease (DED) (L36232) Links in PDF documents are not guaranteed to work. To follow a web link,

More information

Meibomian gland dysfunction

Meibomian gland dysfunction SPECIAL REPORT Meibomian gland dysfunction June 2011 The mere formulation of a problem is far more essential than its solution To raise new questions, new possibilities, to regard old problems from a new

More information

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary Ophthalmic Immunomodulators Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,4 Agent Indication Dosage and Administration Restasis (cyclosporine ophthalmic emulsion)

More information

The estimation of tear volume or secretion is regarded as

The estimation of tear volume or secretion is regarded as Strip Meniscometry: A New and Simple Method of Tear Meniscus Evaluation Murat Dogru, 1,2 Katsushi Ishida, 3 Yukihiro Matsumoto, 1 Eiki Goto, 2 Misaki Ishioka, 4 Takashi Kojima, 5 Tateki Goto, 6 Megumi

More information

Effect of nonisotonic solutions on tear film osmolality. Frank J. Holly and David W. Lamberts

Effect of nonisotonic solutions on tear film osmolality. Frank J. Holly and David W. Lamberts Effect of nonisotonic solutions on tear film osmolality Frank J. Holly and David W. Lamberts We found that the original osmolality of the tear film is regained rapidly subsequent to the installation of

More information

Prevalence of Dry Eye in Patients Presenting With Symptoms Suggestive of Dry Eye

Prevalence of Dry Eye in Patients Presenting With Symptoms Suggestive of Dry Eye IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 3 Ver.16 March. (2018), PP 07-12 www.iosrjournals.org Prevalence of Dry Eye in Patients Presenting

More information

How to Diagnose the Ocular Surface Disease in Treated Glaucoma Patients. Gemma Caterina Maria Rossi

How to Diagnose the Ocular Surface Disease in Treated Glaucoma Patients. Gemma Caterina Maria Rossi How to Diagnose the Ocular Surface Disease in Treated Glaucoma Patients Gemma Caterina Maria Rossi University Eye Clinic of Pavia, Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo

More information

Visionary Optics. SynergEyes. North Suburban Vision Consultants, Ltd. Keratoconus Specialists of Illinois. S. Barry Eiden, OD, FAAO

Visionary Optics. SynergEyes. North Suburban Vision Consultants, Ltd. Keratoconus Specialists of Illinois. S. Barry Eiden, OD, FAAO New Technologies in the diagnosis and management of dry Eye S. Barry Eiden, OD, FAAO North Suburban Vision Consultants, Ltd. Keratoconus Specialists of Illinois International Keratoconus Academy EyeVis

More information

Efficacy and Safety of Diquafosol Ophthalmic Solution in Patients with Dry Eye Syndrome: A Japanese Phase 2 Clinical Trial

Efficacy and Safety of Diquafosol Ophthalmic Solution in Patients with Dry Eye Syndrome: A Japanese Phase 2 Clinical Trial Efficacy and Safety of Ophthalmic Solution in Patients with Dry Eye Syndrome: A Japanese Phase 2 Clinical Trial Yukihiro Matsumoto, MD, 1 Yuichi Ohashi, MD, 2 Hitoshi Watanabe, MD, 3 Kazuo Tsubota, MD,

More information

Tear clearance measurement in patients with dry eye syndrome using quantitative lacrimal scintigraphy

Tear clearance measurement in patients with dry eye syndrome using quantitative lacrimal scintigraphy ORIGINAL ARTICLE Annals of Nuclear Medicine Vol. 19, No. 7, 581 587, 2005 Tear clearance measurement in patients with dry eye syndrome using quantitative lacrimal scintigraphy Esra Arzu GENCOGLU,* Dilek

More information

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome

Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Policy Number: 9.03.29 Last Review: 5/2018 Origination: 9/2013 Next Review: 11/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue

More information

10/27/2017. Evidence for Technology in the Treatment of Dry Eye COPE: AS. Dry eye. Dry eye

10/27/2017. Evidence for Technology in the Treatment of Dry Eye COPE: AS. Dry eye. Dry eye Evidence for Technology in the Treatment of Dry Eye COPE: 44090-AS Chris Lievens, OD MS FAAO Professor Chief of staff Southern college of optometry Dry eye Chronic Multifactorial Characterized by disturbances

More information

Dry eye, a common condition often manifested with visual

Dry eye, a common condition often manifested with visual Cornea Screening for Meibomian Gland Disease: Its Relation to Dry Eye Subtypes and Symptoms in a Tertiary Referral Clinic in Singapore Louis Tong, 1,2,3 Shyam S. Chaurasia, 2 Jodhbir S. Mehta, 1,2,3 and

More information

JMSCR Vol 07 Issue 04 Page April 2019

JMSCR Vol 07 Issue 04 Page April 2019 www.jmscr.igmpublication.org Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i4.19 Original Research Article Use of Plasma Rich in Growth Factors

More information

Introducing a New Parameter for the Assessment of the Tear Film Lipid Layer

Introducing a New Parameter for the Assessment of the Tear Film Lipid Layer Cornea Introducing a New Parameter for the Assessment of the Tear Film Lipid Layer Michael H. Ring, 1,2 Dieter F. Rabensteiner, 3 Jutta Horwath-Winter, 3 Ingrid Boldin, 3 Robert Hörantner, 3,4 and Thomas

More information

Meibomian gland Dropout in Chinese cataract patients.

Meibomian gland Dropout in Chinese cataract patients. Biomedical Research 2017; 28 (7): 3072-3077 ISSN 0970-938X www.biomedres.info Meibomian gland Dropout in Chinese cataract patients. Jinling Ge 1,2#, Lian Duan 3#, Chaoqing Wang 2, Xiuhua Zheng 2, Lihua

More information

Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection

Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection Eur J Ophthalmol 2014; 24 ( 6 ): 830-834 DOI: 10.5301/ejo.5000482 ORIGINAL ARTICLE Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection Sibel Kocabeyoglu, Hande

More information

Prevalence of dry eye disease in type 2 diabetic patients and its co-relation with the duration, glycemic control and retinopathy

Prevalence of dry eye disease in type 2 diabetic patients and its co-relation with the duration, glycemic control and retinopathy Al Am een J Med Sci 2015; 8(3):225-229 US National Library of Medicine enlisted journal ISSN 0974-1143 SHORT COMM UN ICAT ION C O D E N : A A J MB G Prevalence of dry eye disease in type 2 diabetic patients

More information

Colleen Riley, O.D., M.S., F.A.A.O., Graeme Young, M.Phil., Ph.D., F.C.Optom., D.C.L.P., F.A.A.O., and Robin Chalmers, O.D., F.A.A.O.

Colleen Riley, O.D., M.S., F.A.A.O., Graeme Young, M.Phil., Ph.D., F.C.Optom., D.C.L.P., F.A.A.O., and Robin Chalmers, O.D., F.A.A.O. Eye & Contact Lens 32(6): 281 286, 2006 2006 Contact Lens Association of Ophthalmologists, Inc. Prevalence of Ocular Surface Symptoms, Signs, and Uncomfortable Hours of Wear in Contact Lens Wearers: The

More information

Dry eye update: new diagnostic and management strategies

Dry eye update: new diagnostic and management strategies Contact Lens Update CLINICAL INSIGHTS BASED IN CURRENT RESEARCH February 27, 2018 Sruthi Srinivasan is a clinical research manager at the Centre for Ocular Research & Education, and a research assistant

More information

Current Treatment and Management of Dry Eye

Current Treatment and Management of Dry Eye Current Treatment and Management of Dry Eye David I. Geffen, OD, FAAO David I Geffen, OD, FAAO Consultant/Advisor/Speaker Accufocus Alcon AMO Annidis Bausch + Lomb Bruder Healthcare EyeBrain Optovue Revision

More information

Overview. NEI Definition of Dry Eye. Prevalence of Dry Eye 2/1/2018. The Dry Eye Story A Real Tear Jerker. Disclosures

Overview. NEI Definition of Dry Eye. Prevalence of Dry Eye 2/1/2018. The Dry Eye Story A Real Tear Jerker. Disclosures Percentage of Responses Percentage of Responses 2/1/2018 The Dry Eye Story A Real Tear Jerker Disclosures University of Houston College of Optometry njoy Vision Center BioTissue, Inc. OCuSOFT, Inc. Shire

More information

Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease

Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease Article https://doi.org/10.1167/tvst.7.5.31 Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease Jae Yong Park 1, Bum Gi Kim

More information

Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK)

Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK) Meibomian Gland Dysfunction: What Does It Mean James P. McCulley, MD, FACS, FRCOph(UK) David Bruton, Jr. Professor of Ophthalmology Chairman, Department of Ophthalmology The University of Texas Southwestern

More information

Dry eye prevalence and attributable risk factors in the eastern Madhya Pradesh

Dry eye prevalence and attributable risk factors in the eastern Madhya Pradesh Research Article Dry eye prevalence and attributable risk factors in the eastern Madhya Pradesh Pankaj Choudhary, Charudatt Chalisgaonkar, Sujata Lakhtakia, Anamika Dwivedi, Shekhar kain Department of

More information

Ocular Surface Disease Workshop Walter O. Whitley, OD, MBA, FAAO Michael Cooper, OD Whitney Hauser, OD Scott Hauswirth, OD, FAAO

Ocular Surface Disease Workshop Walter O. Whitley, OD, MBA, FAAO Michael Cooper, OD Whitney Hauser, OD Scott Hauswirth, OD, FAAO Ocular Surface Disease Workshop Walter O. Whitley, OD, MBA, FAAO Michael Cooper, OD Whitney Hauser, OD Scott Hauswirth, OD, FAAO Description As our understanding of the ocular surface spectrum has evolved,

More information

BARRY A. SCHECHTER ABSTRACT

BARRY A. SCHECHTER ABSTRACT JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Volume 22, Number 2, 2006 Mary Ann Liebert, Inc. The Evaluation of Ketorolac (Acular LS ) to Improve Patient Comfort During the Induction Phase of Cyclosporin-A

More information

IMPACT OF EVAPORATION ON AQUEOUS TEAR LOSS

IMPACT OF EVAPORATION ON AQUEOUS TEAR LOSS IMPACT OF EVAPORATION ON AQUEOUS TEAR LOSS BY James P. McCulley MD,* Eduardo Uchiyama MD, Joel D. Aronowicz MD, AND Igor A. Butovich PhD ABSTRACT Purpose: To determine the impact of evaporation on preocular

More information

1/23/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX.

1/23/2018. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX. William D. Townsend, O.D., F.A.A.O. Advanced Eye Care Canyon, TX Adjunct Professor UHCO Houston, TX drbilltownsend@gmail.com 1 Alcon CIBA Odyssey Medical Science Based Health Shire TearLab Any product

More information

Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease

Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease Mun et al. BMC Ophthalmology (2018) 18:237 https://doi.org/10.1186/s12886-018-0910-3 RESEARCH ARTICLE Open Access Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film

More information

OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY

OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY OCULAR SURFACE DISEASE SYNDROMES WAYNE ISAEFF, MD LOMA LINDA UNIVERSITY DEPARTMENT OF OPHTHALMOLOGY SURFACE DISEASE DRY EYE DYSFUNCTIONAL TEARS SYND ALLERGIC DISORDERS MEIBOMIAN GLAND PROBLEMS OCULAR IMMUNE

More information

JMSCR Vol 05 Issue 06 Page June 2017

JMSCR Vol 05 Issue 06 Page June 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i6.141 Pterygium and Dry Eye- A Clinical Correlation

More information

Dry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6

Dry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6 Dry eye syndrome The aim of this information sheet is to answer any questions you may have about dry eye syndrome. If you have any further questions or concerns, please ask a doctor or nurse caring for

More information

T a variety of ocular disorders with

T a variety of ocular disorders with ACTA OPHTHALMOLOGICA SCANDINAVICA 1997 - A comparative study of polyacrylic acid (Viscotears@) liquid gel versus polyvinylalcohol in the treatment of dry eyes J. Brodwall', G. Alme', S. Gedde-Dahl', J.

More information

Effects of topical timolol and latanoprost by tear film evaluation and impression cytology.

Effects of topical timolol and latanoprost by tear film evaluation and impression cytology. Research Article http://www.alliedacademies.org/ophthalmic-and-eye-research/ Effects of topical timolol and latanoprost by tear film evaluation and impression cytology. Archimedes Lee D Agahan* 1, Jazel

More information

Efficacy of Topical Pilocarpine in the Management of Primary Aqueous Tear Deficiency: An Initial Study

Efficacy of Topical Pilocarpine in the Management of Primary Aqueous Tear Deficiency: An Initial Study Original Article Efficacy of Topical Pilocarpine in the Management of Primary Aqueous Tear Deficiency: An Initial Study Ma. Theresa B. Urriquia, MD and Jose David F. Marin, Jr., MD Department of Ophthalmology

More information

Improve the Diagnosis, Management and Treatment of Inflammatory Dry Eye

Improve the Diagnosis, Management and Treatment of Inflammatory Dry Eye Improve the Diagnosis, Management and Treatment of Inflammatory Dry Eye USING INFLAMMADRY TO IDENTIFY INFLAMMATION IN DRY EYE PATIENTS FACILITATES TARGETED TREATMENT AND BETTER OUTCOMES. HIGHLIGHTS FROM

More information

Agreement in dry eye management between optometrists and general practitioners in primary health care in the Netherlands

Agreement in dry eye management between optometrists and general practitioners in primary health care in the Netherlands The final publication is available at Elsevier via http://dx.doi.org/10.1016/j.clae.2015.03.005 2015. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/

More information

Original Article The influence of long-term corneal contact lens wearing on the stability and quality of tear film in Qinghai

Original Article The influence of long-term corneal contact lens wearing on the stability and quality of tear film in Qinghai Int J Clin Exp Med 2016;9(5):8416-8420 www.ijcem.com /ISSN:1940-5901/IJCEM0020163 Original Article The influence of long-term corneal contact lens wearing on the stability and quality of tear film in Qinghai

More information

Dry Eye Disease Update

Dry Eye Disease Update Dry Eye Disease Update Feb 2013 Dr. Samuel Kim Director of Physician Training earscience, Inc. skim@tearscience.com Iconoclasts The Dr. Who Drank Infectious Broth, Gave Himself an Ulcer, and Solved a Medical

More information

Breaking the Cycle. Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai

Breaking the Cycle. Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai Lin, Garg Ophthalmology Times 1 Breaking the Cycle Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai Abstract A 32 year-old female with a history of LASIK surgery

More information

Diagnosing the severity of dry eye: a clear and practical algorithm

Diagnosing the severity of dry eye: a clear and practical algorithm 1 Quinze-Vingts National Ophthalmology Hospital, Paris, France 2 UPMC University, Paris 6, Vision Institute, INSERM UMRS968, CNRS UMR7210, Paris, France 3 University of Versailles Saint- Quentin en Yvelines,

More information

MATERIALS AND METHODS

MATERIALS AND METHODS Conjunctival and Corneal Pneumatic Sensitivity Is Associated with Signs and Symptoms of Ocular Dryness Ping Situ, Trefford L. Simpson, Desmond Fonn, and Lyndon W. Jones PURPOSE. To investigate the relationships

More information

Identifying Sjögren's Syndrome. These include cholinergic blockade from autoantibodies to muscarinic acetylcholine

Identifying Sjögren's Syndrome. These include cholinergic blockade from autoantibodies to muscarinic acetylcholine Identifying Sjögren's Syndrome Melissa Barnett, OD, FAAO Melissa Barnett, OD, FAAO is a Principal Optometrist at the UC Davis Medical Center in Sacramento. She specializes in anterior segment disease and

More information

No Conflict of Interest to Report Charles Stockwell, O.D

No Conflict of Interest to Report Charles Stockwell, O.D OH MY!!! DRY EYE!!! No Conflict of Interest to Report Charles Stockwell, O.D Charles.stockwell@ttuhsc.edu The Problem 1 Filamentary Keratitis Keratoconjunctivitis sicca, or dry eye syndrome, is the most

More information

OVERCOMING THE CHALLENGES OF OPHTHALMIC DELIVERY USING AQUEOUS-FREE TECHNOLOGY: REDEFINING DRY EYE DISEASE

OVERCOMING THE CHALLENGES OF OPHTHALMIC DELIVERY USING AQUEOUS-FREE TECHNOLOGY: REDEFINING DRY EYE DISEASE OVERCOMING THE CHALLENGES OF OPHTHALMIC DELIVERY USING AQUEOUS-FREE TECHNOLOGY: REDEFINING DRY EYE DISEASE Traditional aqueous vehicles for topical ophthalmic medications suffer from a number of limitations.

More information

David Clark, MD Chief Medical Officer Aldeyra Therapeutics, Lexington, MA. ARVO: April 30th, 2018

David Clark, MD Chief Medical Officer Aldeyra Therapeutics, Lexington, MA. ARVO: April 30th, 2018 A Randomized, Double-Masked, Parallel-Group, Phase 2a Dry Eye Disease Clinical Trial to Evaluate the Safety and Efficacy of Topical Ocular ADX-102 (Reproxalap), a Novel Aldehyde Sequestering Agent David

More information